YES Securities' research report on Heranba Industries
Heranba Industries posted a disappointing set of numbers wherein consolidated revenue declined sharply by 30%YoY and 34%QoQ to Rs2.76Bn. Due to benign demand and higher channel inventory, revenue from technical segment (49% of Revenue) declined sharply by 51%YoY and 45%QoQ. Company reported lowest quarterly margin of 8.6%, as compared to 18% in Q3FY22 and 15.6% in Q2FY23. Margin contracted due to high inventory cost and low volume uptake. Usually, in Q3 & Q4 demand from exports is buoyant, but due to on‐going global scenario, demand continues to remain lackluster. However, demand from China (25% of exports) is likely to improve post Chinese New‐year. Moreover, management expects flattish top‐line growth for FY23 (earlier 12‐15% growth guidance) and guided for 18‐20% growth in FY24E, which will be driven by better demand coupled with contribution from new capacities, introduction of new products & supply to new geographies. Due to ongoing global destocking, declining prices of pyrethroids and other insecticide molecules, we expect near term outlook will continue to be challenging for the company.
Outlook
Owing to multiple headwinds in terms of demand as well as margins, we have revised our FY24E EPS to Rs.37.3 (revised downward by 32%) and revalued the company at P/E(x) multiple of 12x on FY24E EPS. Hence though we maintain our BUY rating on the stock, we have revised our target price to Rs447.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
